Applications to transfer an authorisation are generally submitted by the future Marketing Authorisation Holder. Applications for medicinal products managed by the previous Marketing Authorisation Holder in eCTD format may, according to the revised Therapeutic Products Act, no longer be submitted outside the eCTD Life Cycle. The rule of thumb is «once eCTD, always eCTD». This means that the future Marketing Authorisation Holder, as the company submitting the application, has to submit the application to transfer the authorisation in a subsequent eCTD sequence via the eGov portal. Swissmedic merges the eCTD Life Cycle.. The future Marketing Authorisation Holder should check that the application appears correctly on the Swissmedic portal, once the application has been submitted.